/
/
ACESABIO is hosting a strategic meeting at BioSpain2025 to promote a common agenda and strengthen territorial, scientific, and industrial cooperation among Spanish health clusters

ACESABIO is hosting a strategic meeting at BioSpain2025 to promote a common agenda and strengthen territorial, scientific, and industrial cooperation among Spanish health clusters

15 de October de 2025

The participation of the Alliance of Spanish Health Clusters (ACESABIO) at BioSpain—which brings together 12 regional clusters from 10 autonomous communities and represents more than 1,050 entities—provided new momentum to consolidate the health sector as a driver of knowledge, innovation, and economic specialization.

  • The Balearic Islands are part of the Alliance of Spanish Health Clusters through the Biotechnology and Biomedical Cluster (BIOIB), represented by its manager, Zara Pons.
  • ACESABIO reaffirmed its commitment to engaging with the key issues at the heart of the European regulatory debate on health, contributing from a technical and coordinated perspective within the sector, so that adaptation to new regulations keeps pace with innovation.

Barcelona, October 10, 2025.—The Alliance of Spanish Health Clusters (ACESABIO) participated in the 12th edition of BioSpain, the leading national event and one of Europe’s premier forums on biotechnology and life sciences, which brought together more than 2,000 professionals and representatives from 30 countries in Barcelona from October 7 to 9.

The conference focused on innovation, sustainability, and artificial intelligence applied to healthcare as the pillars of a new era for the sector, aimed at strengthening Europe’s strategic autonomy and consolidating a more competitive economic and healthcare model. The program also addressed key issues such as investment and international partnerships, training and attracting specialized talent, and the European regulatory challenges that determine innovation’s access to the market.

In this context, the role of biotechnology as a driver of industrial and healthcare transformation was emphasized, as was the need to strengthen the connection between science, business, and investment to accelerate knowledge transfer and the development of new biomedical solutions. In this regard, health clusters, represented by ACESABIO, play an essential coordinating role, acting as hubs for regional cooperation that help consolidate an innovative, cohesive, and competitive biohealth ecosystem, poised to lead an unprecedented transformation in the sector’s future.

During the meeting, ACESABIO held a working session in which it defined the strategic lines of collaboration for the coming years. Among its priority objectives are strengthening interregional cooperation among Spanish health clusters, promoting innovation, and consolidating the sector’s position as a driver of economic growth and knowledge generation.

Representatives from the leading regional clusters, such as Zara Pons, manager of the Balearic Islands Biotechnology and Biomedical Cluster (BIOIB), emphasized that biotechnology and innovation in health are undergoing a period of maturity and sustained growth in Spain. To reinforce this trend, ACESABIO is committed to strengthening collaboration among autonomous communities by organizing joint initiatives that enhance the competitiveness and international visibility of the biotech and healthcare ecosystem.

The alliance maintains an active presence in European regulatory debates, advocating for constructive and coordinated dialogue with the relevant authorities to ensure a streamlined, transparent, and innovation-friendly environment. In this regard, the health clusters emphasized the need to align common positions on strategic issues, such as the Notified Bodies.

ACESABIO welcomed the recent designation of the National Center for the Certification of Medical Devices (CNCps) under the IVDR Regulation and emphasized the need to strengthen national certification capacity and maintain an open dialogue with the authorities to facilitate market access and support the sector’s growth.

Another priority area for the alliance is specialized training and attracting talent, both of which are essential for strengthening human capital and improving the sector’s competitiveness. Likewise, ACESABIO committed to promoting the use of collaborative technology platforms that keep the Spanish biotech community interconnected, fostering cooperation among regions, research centers, companies, and government agencies, and promoting the exchange of knowledge, projects, and opportunities.

With plans to expand into new communities and a shared work agenda, ACESABIO is establishing itself as a national platform for cooperation aimed at promoting innovation, knowledge transfer, and improving the competitiveness of the biopharmaceutical sector in Spain and Europe.

About ACESABIO

Officially established in late 2023, ACESABIO brings together 12 regional health and biosciences clusters representing 10 autonomous communities:
, Arahealth (Aragón), Basque Health Cluster (Basque Country), BIOIB (Balearic Islands), Bioga (Galicia), Bioval (Valencian Community), Catalonia Health (Catalonia), the Extremadura Social and Health Cluster, Clúster Saúde de Galicia (Galicia), Navarra Health Cluster (Navarra), Clúster SIVI (Castile and León), Ticbiomed (Murcia), and WeMind Cluster (Catalonia).

Overall, ACESABIO represents 1,050 entities, including SMEs (73%), startups (18%), corporations (15%), knowledge centers, and patient associations, with an aggregate revenue exceeding 27,000 million euros and more than 378,000 direct jobs. This breadth gives it aunique level of representativenessin the sector and makes it a key partner for promoting R&D&I and interregional collaboration.The Alliance actively works to improve the competitiveness of companies in the sector, promote knowledge transfer, and foster collaboration among science, business, government, and civil society under the quadruple helix model. Finally, BIOIB and a delegation from the Balearic Islands Government’s Department of Health, represented by Gema Jiménez, head of the Health Research Service, and Adrián Fernández, an IB-Salut physician specializing in AI, toured the fair together, visiting the most innovative digital health exhibits and exchanging views on the future of healthcare.

Stay up to date with Cluster News

News
Manduca Protein joins the BIOIB Cluster
News
BIOIB at Mobile World Congress 2025 confirms the boom in health innovation worldwide
News
Biotech innovation to revolutionize anti-aging treatments
News
DRIVING HEALTHCARE TECHNOLOGY SOLUTIONS